FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2344018110> ?p ?o ?g. }

• W2344018110 endingPage "64389" @default.
• W2344018110 startingPage "64380" @default.
• W2344018110 abstract "// Chien-Hua Chen 1, 2, 3 , Cheng-Li Lin 4, 5 , Chia-Hung Kao 6, 7 1 Digestive Disease Center, Show-Chwan Memorial Hospital, Changhua, Taiwan 2 Department of Food Science and Technology, Hung Kuang University, Taichung, Taiwan 3 Chung Chou University of Science and Technology, Yuanlin Township, Changhua, Taiwan 4 Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan 5 College of Medicine, China Medical University, Taichung, Taiwan 6 Graduate Institute of Clinical Medical Science, School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan 7 Department of Nuclear Medicine and PET Center, China Medical University Hospital, Taichung, Taiwan Correspondence to: Chia-Hung Kao, email: d10040@mail.cmuh.org.tw Keywords: metabolic disorder, gallbladder stone disease, prostate cancer Received: February 05, 2016     Accepted: April 16, 2016     Published: April 27, 2016 ABSTRACT Objectives: Chronic inflammation and abnormal cholesterol metabolism are involved in the pathogenesis of gallbladder stone disease (GSD) and that of prostate cancer in experimental studies. We assessed the association between GSD and prostate cancer in this population-based study. Results: The cumulative incidence of prostate cancer (log-rank test: P <.001) and the risk of prostate cancer (1.64 vs 1.14 per 10 000 person-y, adjusted hazard ratio [aHR] = 1.30, 95% confidence interval [CI] = 1.22-1.39) were greater in the patients with GSD than in those without GSD. Furthermore, the risk of prostate cancer increased with the time of follow-up after a diagnosis of GSD, particularly after 9 years of follow-up (aHR = 1.95, 95% CI = 1.74-2.19). Materials and Methods: We identified 9496 patients who were diagnosed with GSD between 1998 and 2011 from Taiwan’s Longitudinal Health Insurance Database 2000 as the study cohort. We randomly selected 37 983 controls from the non-GSD population and used frequency matching by age, sex, and index year for the control cohort. All patient cases were followed until the end of 2011 to measure the incidence of prostate cancer. Conclusion: GSD is associated with an increased risk of prostate cancer, and the risk increases with the time of follow-up after a diagnosis of GSD." @default.
• W2344018110 created "2016-06-24" @default.
• W2344018110 creator A5005660358 @default.
• W2344018110 creator A5036699979 @default.
• W2344018110 creator A5037754552 @default.
• W2344018110 date "2016-04-27" @default.
• W2344018110 modified "2023-10-17" @default.
• W2344018110 title "Association between gallbladder stone disease and prostate cancer: A nationwide population-based study" @default.
• W2344018110 cites W1553274044 @default.
• W2344018110 cites W1663819836 @default.
• W2344018110 cites W1965037168 @default.
• W2344018110 cites W1965547639 @default.
• W2344018110 cites W1968506424 @default.
• W2344018110 cites W1979538859 @default.
• W2344018110 cites W1979700533 @default.
• W2344018110 cites W1981462833 @default.
• W2344018110 cites W2002281127 @default.
• W2344018110 cites W2003197370 @default.
• W2344018110 cites W2005251132 @default.
• W2344018110 cites W2011674538 @default.
• W2344018110 cites W2022733347 @default.
• W2344018110 cites W2026707626 @default.
• W2344018110 cites W2029449503 @default.
• W2344018110 cites W2040935952 @default.
• W2344018110 cites W2049331847 @default.
• W2344018110 cites W2059724367 @default.
• W2344018110 cites W2061006382 @default.
• W2344018110 cites W2065669917 @default.
• W2344018110 cites W2067082288 @default.
• W2344018110 cites W2078107567 @default.
• W2344018110 cites W2089366133 @default.
• W2344018110 cites W2105559278 @default.
• W2344018110 cites W2108649846 @default.
• W2344018110 cites W2124316292 @default.
• W2344018110 cites W2125721892 @default.
• W2344018110 cites W2126071318 @default.
• W2344018110 cites W2129631700 @default.
• W2344018110 cites W2131226025 @default.
• W2344018110 cites W2137586561 @default.
• W2344018110 cites W2158734599 @default.
• W2344018110 cites W2160188142 @default.
• W2344018110 cites W2162923066 @default.
• W2344018110 cites W2166164585 @default.
• W2344018110 cites W2171294131 @default.
• W2344018110 cites W2189171281 @default.
• W2344018110 cites W2323502297 @default.
• W2344018110 cites W2327474156 @default.
• W2344018110 cites W2916392902 @default.
• W2344018110 doi "https://doi.org/10.18632/oncotarget.9062" @default.
• W2344018110 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5325450" @default.
• W2344018110 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27147576" @default.
• W2344018110 hasPublicationYear "2016" @default.
• W2344018110 type Work @default.
• W2344018110 sameAs 2344018110 @default.
• W2344018110 citedByCount "15" @default.
• W2344018110 countsByYear W23440181102017 @default.
• W2344018110 countsByYear W23440181102018 @default.
• W2344018110 countsByYear W23440181102020 @default.
• W2344018110 countsByYear W23440181102021 @default.
• W2344018110 countsByYear W23440181102022 @default.
• W2344018110 crossrefType "journal-article" @default.
• W2344018110 hasAuthorship W2344018110A5005660358 @default.
• W2344018110 hasAuthorship W2344018110A5036699979 @default.
• W2344018110 hasAuthorship W2344018110A5037754552 @default.
• W2344018110 hasBestOaLocation W23440181101 @default.
• W2344018110 hasConcept C121608353 @default.
• W2344018110 hasConcept C126322002 @default.
• W2344018110 hasConcept C143998085 @default.
• W2344018110 hasConcept C207103383 @default.
• W2344018110 hasConcept C2780192828 @default.
• W2344018110 hasConcept C2908647359 @default.
• W2344018110 hasConcept C29456083 @default.
• W2344018110 hasConcept C44249647 @default.
• W2344018110 hasConcept C71924100 @default.
• W2344018110 hasConcept C99454951 @default.
• W2344018110 hasConceptScore W2344018110C121608353 @default.
• W2344018110 hasConceptScore W2344018110C126322002 @default.
• W2344018110 hasConceptScore W2344018110C143998085 @default.
• W2344018110 hasConceptScore W2344018110C207103383 @default.
• W2344018110 hasConceptScore W2344018110C2780192828 @default.
• W2344018110 hasConceptScore W2344018110C2908647359 @default.
• W2344018110 hasConceptScore W2344018110C29456083 @default.
• W2344018110 hasConceptScore W2344018110C44249647 @default.
• W2344018110 hasConceptScore W2344018110C71924100 @default.
• W2344018110 hasConceptScore W2344018110C99454951 @default.
• W2344018110 hasIssue "39" @default.
• W2344018110 hasLocation W23440181101 @default.
• W2344018110 hasLocation W23440181102 @default.
• W2344018110 hasLocation W23440181103 @default.
• W2344018110 hasLocation W23440181104 @default.
• W2344018110 hasOpenAccess W2344018110 @default.
• W2344018110 hasPrimaryLocation W23440181101 @default.
• W2344018110 hasRelatedWork W2090763189 @default.
• W2344018110 hasRelatedWork W2154948599 @default.
• W2344018110 hasRelatedWork W2516062397 @default.
• W2344018110 hasRelatedWork W2792916732 @default.
• W2344018110 hasRelatedWork W2793335702 @default.
• W2344018110 hasRelatedWork W2913113213 @default.

• next